Susan Bobulsky, Chief Commercial Officer, MRD at Adaptive Biotechnologies Corp (ADPT), sold 487 shares at $22.00 ($11K) on 2026-07-01, disclosed to the SEC on 2026-07-06.
Scheduled sale ($11k) by Chief Commercial Officer, MRD under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ADPT | SELL | 2026-08-12 | $75K | — | Filing → |
| ADPT | SELL | 2026-08-03 | $31K | — | Filing → |
| ADPT | SELL | 2026-07-20 | $115K | — | Filing → |